More FDA Skepticism for ALS Drug Second Time Around

(MedPage Today) -- Even with new data, FDA reviewers remain skeptical about AMX0035, the investigational drug for amyotrophic lateral sclerosis (ALS) getting a rare second chance before an FDA advisory committee on Wednesday. Post hoc analyses...
Source: MedPage Today Public Health - Category: American Health Source Type: news